BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 15799405)

  • 1. [Leflunomide for therapy of rheumatoid arthritis].
    Nakajima A; Yamanaka H
    Nihon Rinsho; 2005 Jan; 63 Suppl 1():493-7. PubMed ID: 15799405
    [No Abstract]   [Full Text] [Related]  

  • 2. Leflunomide, an immunorestoring drug for the therapy of autoimmune disorders, especially rheumatoid arthritis.
    Bartlett RR; Brendel S; Zielinski T; Schorlemmer HU
    Transplant Proc; 1996 Dec; 28(6):3074-8. PubMed ID: 8962190
    [No Abstract]   [Full Text] [Related]  

  • 3. New drugs for rheumatoid arthritis.
    Med Lett Drugs Ther; 1998 Nov; 40(1040):110-2. PubMed ID: 9844625
    [No Abstract]   [Full Text] [Related]  

  • 4. Leflunomide.
    Cohen SB; Iqbal I
    Int J Clin Pract; 2003 Mar; 57(2):115-20. PubMed ID: 12661795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Japan deaths spark concerns over arthritis drug.
    McCurry J
    Lancet; 2004 Feb; 363(9407):461. PubMed ID: 14964006
    [No Abstract]   [Full Text] [Related]  

  • 6. Leflunomide.
    Mehta V; Kisalay S; Balachandran C
    Indian J Dermatol Venereol Leprol; 2009; 75(4):422-4. PubMed ID: 19584481
    [No Abstract]   [Full Text] [Related]  

  • 7. Interstitial lung disease associated with leflunomide.
    Ito S; Sumida T
    Intern Med; 2004 Dec; 43(12):1103-4. PubMed ID: 15645640
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment advances in rheumatoid arthritis.
    Arriola ER; Lee NP
    West J Med; 1999 May; 170(5):278-81. PubMed ID: 10379219
    [No Abstract]   [Full Text] [Related]  

  • 9. Vasculitis associated with the use of leflunomide.
    Macdonald J; Zhong T; Lazarescu A; Gan BS; Harth M
    J Rheumatol; 2004 Oct; 31(10):2076-8. PubMed ID: 15468379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Leflunomide: a new treatment for an old disease].
    Monteagudo Sáez I; López Longo FJ; González Fernández CM; Carreño Pérez L
    Rev Clin Esp; 2000 May; 200 Monog 1():114-8. PubMed ID: 10901036
    [No Abstract]   [Full Text] [Related]  

  • 11. Leflunomide: a review of its use in active rheumatoid arthritis.
    Prakash A; Jarvis B
    Drugs; 1999 Dec; 58(6):1137-64. PubMed ID: 10651393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interstitial lung disease and disease modifying anti-rheumatic drugs.
    Scott DL
    Lancet; 2004 Apr; 363(9416):1239-40. PubMed ID: 15081669
    [No Abstract]   [Full Text] [Related]  

  • 13. Risk of interstitial lung disease associated with leflunomide treatment in Korean patients with rheumatoid arthritis.
    Ju JH; Kim SI; Lee JH; Lee SI; Yoo WH; Choe JY; Chung SH; Lee J; Lee YH; Lee SS; Yoon HJ; Yoon CH; Kim HY; Park SH
    Arthritis Rheum; 2007 Jun; 56(6):2094-6. PubMed ID: 17530652
    [No Abstract]   [Full Text] [Related]  

  • 14. Leflunomide for the treatment of rheumatoid arthritis.
    Olsen NJ; Strand V; Kremer JM
    Bull Rheum Dis; 1999; 48(8):1-4. PubMed ID: 10628065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Emergence of new therapeutic agents for collagen diseases and some of the problems].
    Kawai S
    Nihon Naika Gakkai Zasshi; 2003 Oct; 92(10):1990-6. PubMed ID: 14621590
    [No Abstract]   [Full Text] [Related]  

  • 16. Leflunomide and rheumatoid arthritis: new preparation. Neither the safest nor the most effective slow-acting antirheumatic drug.
    Prescrire Int; 2001 Apr; 10(52):36-9. PubMed ID: 11718154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of inflammation and metalloproteinase expression in synovial tissue by leflunomide and methotrexate in patients with active rheumatoid arthritis. Findings in a prospective, randomized, double-blind, parallel-design clinical trial in thirty-nine patients at two centers.
    Kraan MC; Reece RJ; Barg EC; Smeets TJ; Farnell J; Rosenburg R; Veale DJ; Breedveld FC; Emery P; Tak PP
    Arthritis Rheum; 2000 Aug; 43(8):1820-30. PubMed ID: 10943872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [New drug treatments for rheumatoid arthritis].
    Nordström DC; Konttinen YT
    Duodecim; 2000; 116(11):1221-5. PubMed ID: 11989008
    [No Abstract]   [Full Text] [Related]  

  • 19. Valdecoxib (Bextra)--a new cox-2 inhibitor.
    Med Lett Drugs Ther; 2002 Apr; 44(1129):39-40. PubMed ID: 11981510
    [No Abstract]   [Full Text] [Related]  

  • 20. Leflunomide for active rheumatoid arthritis.
    Ferraccioli GF; De Vita S
    Lancet; 1999 May; 353(9167):1883; author reply 1883-4. PubMed ID: 10359440
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.